Abstract:Background CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). Methods To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. Findings In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Interpretation Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population. CYP1B1 is a P450 enzyme which is involved in the activation of pro-carcinogens to carcinogens as well as oestrogen metabolism. We hypothesised that genetic variants in CYP1B1 may modify individual susceptibility to hepatocellular carcinoma (HCC). To test this hypothesis, we evaluated the associations of three CYP1B1 single nucleotide polymorphisms (SNPs) and HCC risk in a case-control study of 468 HCC cases and 515 cancer-free controls in a Chinese population. The matrix-assisted laser desorption ionization time-of-flight mass spectrometry method and direct DNA sequencing were done to detect these polymorphisms. In overall analysis, the three SNPs rs10012, rs1056836, and rs1800440 were not significantly associated with HCC risk. However, we found that variant genotypes containing the G allele of rs1056836 were associated with a significantly increased risk of HCC among HbsAg-positive individuals (adjusted odds ratio 2.13, 95% confidence interval [CI] 1.18–3.86), but not among HbsAg-negative individuals in the subgroup analysis by HBV carrier status. When stratified by smoking status, we found that the variant GG genotype increased risk of HCC by 13.97-fold (95% CI 1.28–152.94) among smokers. Furthermore, a high risk for liver cirrhosis was noted in HCC patients with rs1056836 CG and GG genotypes compared with CC homozygotes. For the other two SNPs, we did not find any significant evidence of association with HCC risk in any subgroup. Our results suggest that CYP1B1 rs1056836 polymorphism may be an important factor contributing to increased susceptibility and pathological development of HCC in a Chinese population.

<i>PIK3R3</i> Missense and <i>NOTCH2</i> Synonymous Single Nucleotide Polymorphisms Are Associated with Liver Cancer

Impact of NOTCH1 Polymorphisms on Liver Cancer in a Chinese Han Population

Association Between the LINC00673 Rs11655237 C> T Polymorphisms with Cancer Risk in the Chinese Population: A Meta-Analysis

Polymorphisms of a Novel Long Non-Coding RNA RP11-108K3.2 with Colorectal Cancer Susceptibility and Their Effects on Its Expression

PIK3CA Polymorphisms Associated with Susceptibility to Hepatocellular Carcinoma.

Association Between PNPLA3 Gene Polymorphisms and Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma in Han Population in China:a Case-Control Study

Low Frequency of PIK3CA Gene Mutations in Hepatocellular Carcinoma in Chinese Population.

Association of PTEN Gene Polymorphisms with Liver Cancer Risk.

Genetic Polymorphisms Are Associated With The Risk Of Gastric And Colorectal Cancers In A Han Chinese Population

Acyp2 Polymorphisms Are Associated With The Risk Of Liver Cancer In A Han Chinese Population

P0162 CYP1B1 Polymorphisms and Hepatocellular Cancer Risk in a Chinese Population

Association Between P2rx7 Gene and Hepatocellular Carcinoma Susceptibility: A Case-Control Study in A Chinese Han Population

Association Between Two Genetic Variants in Mirna and Primary Liver Cancer Risk in the Chinese Population.

Correlation Between Polymorphisms in DNA Mismatch Repair Genes and the Risk of Primary Hepatocellular Carcinoma for the Han Population in Northern China

Genetic polymorphisms in DNA double-strand break repair genes XRCC5, XRCC6 and susceptibility to hepatocellular carcinoma.

The Association of POLR2E Rs3787016 Polymorphism and Cancer Risk: a Chinese Case–control Study and Meta-Analysis

Mir-300 Rs12894467 Polymorphism May Be Associated with Susceptibility to Primary Lung Cancer in the Chinese Han Population.

Gene polymorphism of cytochrome P450 significantly affects lung cancer susceptibility.

Association between single nucleotide polymorphisms in miRNA196a-2 and miRNA146a and susceptibility to hepatocellular carcinoma in a Chinese population.

The Polymorphism and Haplotypes of PIN1 Gene Are Associated with the Risk of Lung Cancer in Southern and Eastern Chinese Populations

Genetic Variants of P21 and P27 and Hepatocellular Cancer Risk in A Chinese Han Population: A Case-Control Study